Acetic Acid

Acetic Acid

SCHEMBL4824082

CC(=O)O.COCCN1CCC(n2nc(-c3ccc(-c4nc5cc(C)ccc5o4)cc3)c3c(N)ncnc32)C1.N

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 8/20 0.47
EGFR P00533 6/20 0.47
JAK3 P52333 5/20 0.46
JAK2 O60674 4/20 0.46
TYK2 P29597 4/20 0.46
JAK1 P23458 2/20 0.46
SRC P12931 8/20 0.46
IGF1R P08069 3/20 0.46
LCK P06239 3/20 0.46
PLK4 O00444 2/20 0.46
MAPK13 O15264 2/20 0.46
PDPK1 O15530 2/20 0.46
DAPK3 O43293 2/20 0.46
ROCK2 O75116 2/20 0.46
PAK4 O96013 2/20 0.46
ABL1 P00519 2/20 0.46
NTRK1 P04629 2/20 0.46
INSR P06213 2/20 0.46
FYN P06241 2/20 0.46
CDK1 P06493 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL4818871 0.93 AURKA (0.51) BTKEGFRJAK3JAK2TYK2
Acetic Acid SCHEMBL4827149 0.92 BTK (0.48) BTKEGFRJAK3JAK2TYK2
Acetic Acid SCHEMBL6430603 0.90 EGFR (0.58) BTKEGFRJAK3JAK2TYK2
Ammonia Solution, Strong SCHEMBL4820345 0.86 SRC (0.60) BTKEGFRJAK3JAK2TYK2
Acetic Acid SCHEMBL6430342 0.82 EGFR (0.59) BTKEGFRJAK3JAK2TYK2
Ammonia Solution, Strong SCHEMBL4818822 0.82 EGFR (0.58) BTKEGFRJAK3JAK2TYK2
Acetic Acid SCHEMBL7045276 0.82 EGFR (0.62) BTKEGFRJAK3JAK2TYK2
Acetic Acid SCHEMBL6435380 0.82 EGFR (0.55) BTKEGFRJAK3JAK2TYK2
Acetic Acid SCHEMBL4821510 0.82 EGFR (0.71) BTKEGFRJAK3JAK2TYK2
Ammonia Solution, Strong SCHEMBL4828005 0.80 EGFR (0.53) BTKEGFRJAK3JAK2TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332497-B2 As inhibitors of protein kinases ABBOTT GMBH & CO KG (DE) 2008-02-19 US disclosed
US-20040006083-A1 Pyrazolopyrimidines as therapeutic agents ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2004-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006083-A1 Pyrazolopyrimidines as therapeutic agents DPYD, UGT1A1, ABCB1 BTK 1399/4885EGFR 1992/4885JAK3 1336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.